CASCELLA ROBERT 4
Research Summary
AI-generated summary
KORU Medical Director Robert Cascella Receives 3,472-Share Award
What Happened
- Robert Cascella, a director of KORU Medical Systems, Inc. (KRMD), was granted 3,472 shares on April 1, 2026. The shares were acquired at a reported per-share value of $4.32, for a total reported value of $14,999. This transaction is an award/grant (Form 4 code A), an acquisition rather than a sale.
Key Details
- Transaction date: 2026-04-01
- Transaction type/code: Award/Grant (A)
- Shares granted: 3,472 at $4.32 per share; total value reported $14,999
- Shares owned after transaction: Not specified in the filing
- Filing timeliness: Report filed same day (no late filing indicated)
- Notable footnotes: Filing includes standard disclaimer that the statement should not be construed as admission of beneficial ownership; a power of attorney has been previously filed
Context
- An "award" typically reflects a grant of restricted stock or similar equity compensation and is common for directors and executives as part of pay or incentive programs; it is an acquisition of shares, not a sale. This grant is relatively small in dollar terms (~$15k) compared with many executive awards and does not, by itself, indicate broader insider sentiment.